These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23430881)

  • 1. Cerebral edema in maple syrup urine disease despite newborn screening diagnosis and early initiation of treatment.
    Myers KA; Reeves M; Wei XC; Khan A
    JIMD Rep; 2012; 3():103-6. PubMed ID: 23430881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous administration of a branched-chain amino-acid-free solution in children and adults with acute decompensation of maple syrup urine disease: a prospective multicentre observational study.
    Alili JM; Berleur MP; Husson MC; Mention K; Schiff M; Arnoux JB; Brassier A; Guemman AS; Grisel C; Dubois S; Abi-Wardé MT; Broissand C; Servais A; Dao M; de Lonlay P
    Orphanet J Rare Dis; 2022 May; 17(1):202. PubMed ID: 35578286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maple syrup urine disease: diffusion-weighted MRI findings during acute metabolic encephalopathic crisis.
    Kilicarslan R; Alkan A; Demirkol D; Toprak H; Sharifov R
    Jpn J Radiol; 2012 Jul; 30(6):522-5. PubMed ID: 22476847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging Findings in Maple Syrup Urine Disease: A Case Report.
    Kathait AS; Puac P; Castillo M
    J Pediatr Neurosci; 2018; 13(1):103-105. PubMed ID: 29899783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Maple syrup urine disease of neonates: report of two cases and review of literature].
    Chen Z; Luo F; Wu XJ; Shi LP
    Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):680-4. PubMed ID: 21092528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation.
    Jan W; Zimmerman RA; Wang ZJ; Berry GT; Kaplan PB; Kaye EM
    Neuroradiology; 2003 Jun; 45(6):393-9. PubMed ID: 12736767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain magnetic resonance imaging findings and radiologic review of maple syrup urine disease: Report of three cases.
    Li Y; Liu X; Duan CF; Song XF; Zhuang XH
    World J Clin Cases; 2021 Mar; 9(8):1844-1852. PubMed ID: 33748233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maple syrup urine disease: diffusion-weighted and diffusion-tensor magnetic resonance imaging findings.
    Parmar H; Sitoh YY; Ho L
    J Comput Assist Tomogr; 2004; 28(1):93-7. PubMed ID: 14716239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease.
    Zinnanti WJ; Lazovic J; Griffin K; Skvorak KJ; Paul HS; Homanics GE; Bewley MC; Cheng KC; Lanoue KF; Flanagan JM
    Brain; 2009 Apr; 132(Pt 4):903-18. PubMed ID: 19293241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maple syrup urine disease: clinical, EEG, and plasma amino acid correlations with a theoretical mechanism of acute neurotoxicity.
    Korein J; Sansaricq C; Kalmijn M; Honig J; Lange B
    Int J Neurosci; 1994 Nov; 79(1-2):21-45. PubMed ID: 7744549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of COVID-19 in a Patient With Maple Syrup Urine Disease.
    Morton KF; Goetz RL; Linscott KB; Van Wagoner NJ
    Cureus; 2022 Apr; 14(4):e24368. PubMed ID: 35619835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin ameliorates oxidative stress and DNA damage of rats subjected to a chemically induced chronic model of Maple Syrup Urine Disease.
    Wessler LB; Ise K; Lemos IC; Rezende VL; Duarte MB; Damiani AP; de Oliveira J; de Andrade VM; Streck EL
    Metab Brain Dis; 2020 Aug; 35(6):905-914. PubMed ID: 32297169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous branched-chain amino-acid-free solution for the treatment of metabolic decompensation episodes in Spanish pediatric patients with maple syrup urine disease.
    Sánchez-Pintos P; Meavilla S; López-Ramos MG; García-Cazorla Á; Couce ML
    Front Pediatr; 2022; 10():969741. PubMed ID: 36046474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful pregnancy in maple syrup urine disease: a case report and review of the literature.
    Grünert SC; Rosenbaum-Fabian S; Schumann A; Schwab KO; Mingirulli N; Spiekerkoetter U
    Nutr J; 2018 May; 17(1):51. PubMed ID: 29753318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptotic signaling pathways induced by acute administration of branched-chain amino acids in an animal model of maple syrup urine disease.
    Vilela TC; Scaini G; Furlanetto CB; Pasquali MA; Santos JP; Gelain DP; Moreira JC; Schuck PF; Ferreira GC; Streck EL
    Metab Brain Dis; 2017 Feb; 32(1):115-122. PubMed ID: 27510712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of branched-chain amino acids alters epigenetic regulatory enzymes in an animal model of Maple Syrup Urine Disease.
    Streck EL; Bussular FP; Wessler LB; Duarte MB; Rezende VL; Rodrigues MS; Torres CA; Lemos IS; Candiotto G; Gava FF; de Oliveira J; Valvassori SS
    Metab Brain Dis; 2021 Feb; 36(2):247-254. PubMed ID: 33098071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maple syrup urine disease: further evidence that newborn screening may fail to identify variant forms.
    Puckett RL; Lorey F; Rinaldo P; Lipson MH; Matern D; Sowa ME; Levine S; Chang R; Wang RY; Abdenur JE
    Mol Genet Metab; 2010 Jun; 100(2):136-42. PubMed ID: 20307994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world management of maple syrup urine disease (MSUD) metabolic decompensations with branched chain amino acid-free formulas in France and Germany: A retrospective observational study.
    de Lonlay P; Posset R; Mütze U; Mention K; Lamireau D; Schiff M; Servais A; Arnoux JB; Brassier A; Dao M; Douillard C; Ottolenghi C; Pontoizeau C; Miotto F; Le Mouhaër J
    JIMD Rep; 2021 May; 59(1):110-119. PubMed ID: 33977036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of MSUD by newborn screening allows early intervention without extraneous detoxification.
    Heldt K; Schwahn B; Marquardt I; Grotzke M; Wendel U
    Mol Genet Metab; 2005 Apr; 84(4):313-6. PubMed ID: 15781191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classical maple syrup urine disease and brain development: principles of management and formula design.
    Strauss KA; Wardley B; Robinson D; Hendrickson C; Rider NL; Puffenberger EG; Shellmer D; Moser AB; Morton DH
    Mol Genet Metab; 2010 Apr; 99(4):333-45. PubMed ID: 20061171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.